10th Neurological Disorders Summit | Neurological Disorders Conference

10^th Neurological Disorders Summit (NDS-2025)

April 28-30, 2025 | Frankfurt, Germany | Virtual
Venue: NH Collection Frankfurt Spin Tower, Guterplatz 1, D-60327 Frankfurt Am Main, Frankfurt, Germany

10^th Neurological Disorders Summit (NDS-2025)

April 28-30, 2025 | Frankfurt, Germany | Virtual
Venue: NH Collection Frankfurt Spin Tower, Guterplatz 1, D-60327 Frankfurt Am Main, Frankfurt, Germany

About NDS-2025

We welcome you to the 10^th Neurological Disorders Summit (NDS-2025) on April 28-30, 2025, in Frankfurt, Germany.
The NDS-2025 summit offers a unique opportunity for neuroscientists and physicians to share their research and experiences with leading experts in their fields. The program features keynote speeches from internationally renowned scientists who have shaped modern neuroscience concepts. Additionally, there will be sessions for oral and poster presentations, providing an overview of cutting-edge technologies used to address challenging therapeutic and theoretical issues in neuroscience. NDS-2025 stands out for fostering dialogue between basic and clinical scientists, facilitating these exchanges during both scientific sessions and networking events. The summit aims to be particularly educational and inspiring for young scientists, offering them the chance to interact with leading experts. Germany, the host city, is home to top medical research centers and laboratories and boasts many award-winning ethnic and continental food choices. We are proud to welcome you to this exciting summit and hope you will find the academic and social interactions in Germany rewarding.

News : The Neurological Disorders Summit (NDS) has secured its place among the top five conferences in San Francisco and is the leading event in the medical field: https://offthegrid.com/blog/biggest-conferences-san-francisco-2022/

Scientific Sessions

Neurological disorders: Symptomatology, pathophysiology and etiology
Diagnostics of neurological disorders: Neuroimaging, biomarkers and laboratory studies
Alzheimer's disease, dementia and mild cognitive impairment
Parkinson's disease and other movement disorders
Neuromuscular disorders and peripheral neuropathies
Neurodegenerative diseases
Neuropathological disorders
CNS Neoplasia
Neurotransmitters, neuropeptides and drug targets‏

Neurobehavioral disorders
Prevention, treatment and therapeutic options
Autism and neurodevelopmental disorders
Epilepsy and seizure
Advances in stroke management
Stroke: Prevention, treatment and recovery
Multiple sclerosis and CNS demyelinating disorders
Migraine and headaches
Neuroengineering & rehabilitation
Case studies and ethical issues

Poster presenter Winners

Sofia Vrettou

University of Cologne, Germany
Title: Dysregulated S-glutathionylation and Redox Enzymes in Multiple Murine Organs of Spinal Muscular Atrophy

Hind A. Beydoun

University of Texas Health Science Center at Houston, USA
Title: Mediating and Moderating Effects of Plasma Proteomic Biomarkers on the Association Between Poor Oral Health Problems and Incident Dementia: The UK Biobank Study

Amy Glynn

SMATHERIA, Germany
Title: Peripheral Organs Defects in Spinal Muscular Atrophy: Actin Dysregulation

Ethel Virginia Sticinski

University of Delaware, USA
Title: Caregiver Strain and Quality of Life: Assessing the Moderating Role of Age Among Caregivers of Offspring with Intellectual and Developmental Disabilities

Johanna Mitterreiter

Siemens Healthineers, Germany
Title: Screening for Early Biofluid Markers of Alzheimer’s Disease in an At-risk Population: Design of the PREDICTOM Study

Eulalia Gomez Armengol

Ghent University, Belgium
Title: Ectoine Treatment Stimulates Protein Markers of Autophagy Efficiency in the Duchenne Muscular Dystrophy Mouse Model mdx

Organizing Committee Members

Laxman D. Gangwani

University of Missouri
USA
Chair

Kenneth Blum

Western University College of Medicine, USA
Co-Chair

Jin Jun Luo

Temple University,
USA
Member

Marzia Buonfiglio

Sapienza University of Rome,
Italy
Member

View More

Early Bird Registration

Academic

$ 799

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Industry

$ 899

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Student

$ 449

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Virtual

$ 379

Welcome coffee
Access to All Talks + Posters
Conference material
Lunch, tea / coffee breaks
WiFi in meeting rooms

Report on the 9th Neurological Disorders Summit (NDS-2024)

The 9^thThe 9th NDS-2024 was held from May 06-08, 2024, in a Hybrid mode (In-Person & Virtual) at Barcelona, Spain. About 102 attendees from all over the world participated in NDS-2024, which featured 3-keynote lectures, 55-oral presentations, and 12-poster presentations.

The keynote speakers included Dr. Eduardo Tizzano from Vall d'Hebron University Hospital, Spain; Dr. Antoni Matilla Duenas from Germans Trias i Pujol Research Institute (IGTP), Spain; and Dr. Giulio Pasinetti from Icahn School of Medicine at Mount Sinai, USA. Additionally, Dr. Jin Jun Luo, Editor-in-Chief of the Journal of Neurology and Experimental Neuroscience (JNEN) from Temple University, USA, spoke about “Hurdles in Anti-amyloid Therapy for Alzheimer’s Disease.”

There were also two invited talks by Dr. Soraya L. Valles from the University of Valencia, Spain, and Dr. Laxman D. Gangwani from the University of Missouri at Columbia, USA.